South Korea Vitrification Market Size, Share, and COVID-19 Impact Analysis, By Specimen (Oocytes, Embryo, and Sperm), By End Use (IVF Clinics and Biobanks), and South Korea Vitrification Market Industry Trend, Forecasts to 2035

South Korea Vitrification Market Insights Forecasts to 2035

• The South Korea Vitrification Market Size Was Estimated at USD 159.8 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 12.7% from 2025 to 2035
• The South Korea Vitrification Market Size is Expected to Reach USD 595.5 Million by 2035

According to a Research Report Published by Spherical Insights & Consulting, the South Korea Vitrification Market Size is Anticipated to Reach USD 595.5 Million by 2035, Growing at a CAGR of 12.7% from 2025 to 2035. The market is anticipated to be driven by the growing need for Assisted Reproduction Technologies (ARTs), increased knowledge of reproductive health, and the rise in service providers providing vitrification services.

Market Overview

The vitrification market involves a rapid freezing technique used to preserve biological specimens such as oocytes, embryos, and sperm by preventing ice crystal formation. This method enhances the viability of cells during thawing, making it highly effective for use in fertility treatments and biobanking. The improved survival rates of reproductive cells, increased success in IVF procedures, and support for fertility preservation. The market offers opportunities driven by rising infertility rates, delayed parenthood, and demand for advanced cryopreservation techniques. In South Korea, supportive government initiatives such as subsidies for fertility treatments and public awareness campaigns are encouraging wider adoption.

Report Coverage

This research report categorizes the market for South Korea vitrification market based on various segments and regions forecasts revenue growth, and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea vitrification market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment South Korea vitrification market.

Driving Factors

Rising demand for assisted reproductive technologies (ART), and growing awareness of fertility preservation options. Technological advancements have improved the success rates of oocyte and embryo cryopreservation, boosting clinical adoption. Social trends such as delayed parenthood and elective egg freezing contribute to market growth. Additionally, supportive government policies and funding for fertility treatments, along with expanding IVF clinic infrastructure and medical tourism in countries like South Korea, further fuel the market's expansion.

Restraining Factors

High equipment and cryoprotectant costs make setup prohibitively expensive for smaller clinics, limiting geographic and demographic access. The requirement for skilled personnel adds complexity and cost, especially where training resources are scarce. Additionally, ethical and legal issues such as variable regulations on embryo and gamete storage create regulatory uncertainty and hinder adoption.

Market Segmentation

The South Korea vitrification market share is classified into specimen and end use.

• The oocytes segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea vitrification market is segmented by specimen into oocytes, embryo, and sperm. Among these, the oocytes segment held a significant share in 2024 and is expected to grow at a substantial CAGR during the forecast period. The rising demand for fertility preservation among women, particularly those delaying childbirth for career or health reasons. Advances in vitrification techniques have improved oocyte survival rates and success in assisted reproductive technologies (ART). Increasing awareness about egg freezing, supportive government policies on fertility treatments.

• The IVF clinics segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea vitrification market is segmented by end use into IVF clinics and biobanks. Among these, the IVF clinics segment dominated a share in 2024 and is expected to grow at a significant CAGR during the forecast period. The increasing number of infertility cases and growing acceptance of assisted reproductive technologies. IVF clinics widely adopt vitrification for efficient oocyte and embryo preservation.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea vitrification market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the companies' current news and developments, including product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Samsung Biologics
• IVF Korea
• Hamchoon Womens Clinic
• CHA Fertility Center
• Seoul National University Hospital
• Asan Medical Center
• Maria Fertility Hospital
• Seoul National University Bundang Hospital
• ReproLab
• Jinsung Womens Clinic
• SNUH Fertility Center
• Bioneer Corporation
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea vitrification market based on the below-mentioned segments:

South Korea Vitrification Market, By Specimens

• Oocytes
• Embryo
• Sperm

South Korea Vitrification Market, By End Use

• IVF Clinics
• Biobanks